Skip to content

Lyme disease

Ch. 1 of 8
— CH. 1 · INTRODUCTION —

Contents

Lyme disease

8 sections
  • Lyme disease usually begins with a bite that nobody notices. The tick responsible, in its nymph stage, is about the size of a poppy seed. Its secretions also keep the skin from itching or hurting, so a bite can pass without a trace. The culprit is a Borrelia bacterium carried by Ixodes ticks. It causes the most common tick-borne illness in the Northern Hemisphere, with infections peaking in spring and early summer. This documentary asks why a disease that antibiotics can cure still leaves some people unwell for years. It asks why doctors so often mistake it for something else, and why the famous target-shaped rash is far less reliable than its reputation. It follows the bacterium from a mouse to a tick to a human joint, heart or nerve. And it asks whether any shot can stop the whole cycle.

  • The name erythema migrans translates as "migrating redness," and the rash lives up to it. Roughly 70-80 percent of infected people develop one, usually at the bite site one or two weeks afterward, though the range stretches from 3 to 32 days. Each day it spreads by about 2-3 cm, or around an inch, eventually reaching a diameter anywhere from 5 to 70 cm. The median is 16 cm. It is typically circular or oval, red or bluish, and sometimes has a raised or darker center.

    Skin folds are favorite sites, including the armpit, the groin and the back of the knee. In children, the rash often turns up in the hair, ears or neck. It may feel warm, but it is usually not itchy and is rarely painful. Left alone, it takes up to four weeks to fade. Flu-like symptoms such as fatigue, headache, body aches, fever and chills often arrive with it.

    In about 79 percent of European cases, the rash clears from the center outward and forms the classic bull's-eye. In endemic parts of the United States, that clearing happens in only 19 percent of cases. Most American rashes therefore look nothing like the textbook target.

    Community clinics have been reported to misdiagnose 23-28 percent of these rashes. Spider bites, cellulitis and shingles are the usual wrong answers. The real signature is speed and size, not shape. A Lyme rash is at least 5 cm across, and in half of cases it passes 16 cm. Spider bites tend to appear on the limbs, hurt or itch, swell, and sometimes kill a patch of skin. Cellulitis typically grows around a wound or ulcer, is rarely circular, and becomes swollen and tender. Shingles brings clusters of small blisters along a single nerve's path, and a quick lab test can confirm it.

    Some infections produce no symptoms at all. Studies suggest this happens in under 7 percent of infected people in the United States, against roughly 50-70 percent of cases in Europe.

  • On the East Coast of the United States, the black-legged tick, also called the deer tick, is the main carrier. Its relative Ixodes pacificus, the western black-legged tick, fills that role on the West Coast. Europe's main vector is Ixodes ricinus, known as the sheep tick or castor bean tick. In China, the taiga tick, Ixodes persulcatus, is probably the most important.

    A tick passes through three stages: larva, nymph and adult. Larvae are very rarely infected. Nymphs cause most infections because they are tiny and can feed unnoticed for long periods. In regions with a mild climate, they are most active in late spring and early summer. Adults bite humans less often, and being larger, they are easily spotted and removed.

    Deer are the preferred hosts of adult deer ticks, and tick numbers are much lower where deer are absent. Yet ticks generally do not pick up the bacterium from deer. They get it from small mammals such as the white-footed mouse, and occasionally from birds. Different bacterial species favor different animals. Borrelia afzelii is most often found in ticks that feed on rodents, while Borrelia garinii and Borrelia valaisiana seem tied to birds.

    The western fence lizard adds a twist on the West Coast. Ticks there feed predominantly on hosts like this lizard, which resists Borrelia infection, and that appears to dampen transmission. Ecologists call such animals dilution hosts. A greater diversity of hosts, or of hosts that do not support the pathogen, tends to lower the chance of spread. Evidence that lizards sustain the bacterium is thin, since much of it rests on detecting bacterial DNA rather than showing that lizards infect feeding ticks.

    Ticks carrying Borrelia burgdorferi can also carry Babesia microti and Anaplasma phagocytophilum. These cause babesiosis and human granulocytic anaplasmosis. Among people with early Lyme disease, 2-12 percent also have the anaplasmosis and 2-10 percent have babesiosis, depending on location.

    For all this machinery, transmission is uncommon. Only about 1.2 to 1.4 percent of recognized tick bites result in Lyme disease.

  • Inside the tick's midgut, a bacterial surface protein called OspA clings to a tick receptor known as TROSPA. Once the tick starts feeding, the bacterium turns OspA down and turns up a second protein, OspC. After the bacteria reach the salivary glands, OspC binds Salp15, a tick protein that seems to suppress the host's immune response. Without OspC, infection of a mammal does not succeed.

    Tick saliva also impairs neutrophils, the immune cells needed to clear spirochetes from the skin. Too few of them reach the growing rash, so the bacteria multiply outward and then travel by the bloodstream. The bacterium produces no toxins. Most symptoms therefore come from the immune response to its presence. It can dodge antibodies by lowering the surface proteins they target, varying its VlsE protein, disabling complement, and hiding in the extracellular matrix.

    In 10-20 percent of untreated cases, extra rashes appear at sites unrelated to the bite. About 10-15 percent of untreated people develop neuroborreliosis, typically 4-6 weeks after the bite. In North America, the classic form is facial palsy, affecting 5-10 percent of untreated people and impairing blinking, smiling and chewing. Radiculopathy, an inflammation of spinal nerve roots, causes pain patients describe as unlike any they have felt, worse at night and often wrecking sleep. In European adults, meningitis combined with radiculopathy is called Bannwarth syndrome. Months later, ear symptoms can follow, and in up to 76.5 percent of those cases tinnitus is the main complaint.

    Lyme arthritis strikes up to 60 percent of untreated people, typically starting about six months after infection. It usually involves one or a few joints, often a knee, with large swelling but only mild or moderate pain. Untreated, the swelling fades and then periodically returns. In elderly Europeans, a skin disorder called acrodermatitis chronica atrophicans begins as a reddish-blue patch, often on the backs of the hands or feet. Over weeks or months, the skin turns thin and wrinkled, and then dry and hairless.

    Some claims remain contested. Lyme encephalopathy, with memory trouble and personality changes, is controversial in the United States and has not been reported in Europe. There is no compelling evidence that Lyme disease causes psychiatric or neurodevelopmental disorders. Depression and fibromyalgia are as common among Lyme patients as in the general population.

    Lyme carditis appears in 4-10 percent of untreated cases in the United States and 0.3-4 percent in Europe, usually about a month after the bite. Palpitations occur in 69 percent of those affected. In 19-87 percent, the heart's electrical conduction suffers, producing rhythms that swing within minutes between abnormally slow and abnormally fast. For some people, carditis is the first sign of Lyme disease, arriving with no rash at all.

  • A rash plus time outdoors in tick country within the previous 30 days is enough for a diagnosis, and no laboratory test is needed or recommended. That is partly because antibodies may not yet be detectable when a rash first appears. IgM antibodies are usually first found 2-4 weeks after infection and IgG at 4-6 weeks, and both peak at 6-8 weeks.

    Without a rash or a known exposure, diagnosis rests on blood tests. The CDC recommends a two-tiered protocol. The sensitive ELISA test goes first, and the more specific Western blot follows if the result is positive or equivocal. The bacteria are hard to see in tissue and too slow to grow in culture, so the tests hunt for antibodies instead. As many as 5-20 percent of the normal population carry Lyme antibodies. Testing people with no suggestive history would therefore yield mostly false positives. After the first month, a positive IgM with a negative IgG is generally a false positive. IgM levels collapse 4-6 months after infection, while IgG can stay detectable for years.

    PCR tests, which detect the bacterium's DNA, are much faster than culture but can mislead in both directions. Debris from dead bacteria or contamination causes false positives. Few bacteria circulate in blood or spinal fluid, which causes false negatives. They are recommended mainly for Lyme arthritis, where joint fluid gives a sensitive result. The CDC does not recommend urine antigen tests, PCR tests on urine, or lymphocyte transformation tests.

    In Europe, a definite diagnosis of neuroborreliosis requires a lumbar puncture. The spinal fluid must show raised lymphocytes and locally produced antibodies. In North America, a normal fluid result does not exclude the disease.

    Facial palsy caused by Lyme is often mislabeled as Bell's palsy. Bell's accounts for about 70 percent of one-sided facial palsy, but Lyme can account for about 25 percent of cases where the disease is common. The distinction matters, because corticosteroids help Bell's palsy and harm Lyme facial palsy. Lyme radiculopathy in the limbs is often taken for sciatica. In the trunk it can pass for diverticulitis or acute coronary syndrome.

    Late-stage Lyme, with its many guises, led one reviewer to call it the new "great imitator." Yet everyone with later-stage infection tests positive for antibodies, so a simple blood test can rule Lyme out.

  • For most early localized infections, doctors reach for doxycycline by mouth, since it also works against other tick-borne illnesses. Patients taking it should avoid sun exposure because of the higher risk of sunburn. It is not for children younger than eight or for women who are pregnant or breastfeeding. They receive amoxicillin or cefuroxime axetil instead, and azithromycin is reserved for those who cannot tolerate the others. Cephalexin, the standard cellulitis drug, does not work against Lyme. When a rash could be either condition, the IDSA recommends cefuroxime or amoxicillin/clavulanic acid, which are effective against both.

    Courses run 7-14 days for early localized disease, 14-21 days for early disseminated disease and 14-28 days for late disseminated disease. Intravenous ceftriaxone is the first choice when the heart, joints or nervous system are involved. A regimen longer than 28 days is not recommended, because no evidence shows it helps. Antibody levels can stay elevated for years after a cure, so retesting them tells doctors nothing about success.

    In the United States, full recovery rises from about 64-71 percent at the end of treatment for a rash to roughly 84-90 percent after 30 months. A European follow-up at 32-33 months found lingering symptoms in 50 percent of neuroborreliosis patients, against 16 percent of those who had only a rash. About 90 percent of Lyme facial palsies treated with antibiotics recover fully, a median of 24 days after appearing. About a third of people with Lyme carditis need a temporary pacemaker, and 21 percent are hospitalized. Around 94 percent recover fully, while 5 percent need a permanent pacemaker. Reinfection is not uncommon. In a U.S. study, 6-11 percent of people treated for a rash had another within 30 months, usually from a different Borrelia strain.

    Between 5 and 20 percent of people who contract Lyme disease keep suffering pain, fatigue or cognitive impairment after completing treatment. This is post-treatment Lyme disease syndrome, or PTLDS. Its cause is unknown. One hypothesis is a hidden, persistent infection, though human and animal trials have not supported it. Another is autoimmunity, which follows other infections, including Campylobacter, Chlamydia and strep throat. A third points to leftover debris from the infection. A fourth says the symptoms have nothing to do with Lyme. In studies of people who came to clinics worried about Lyme, 47-80 percent had no evidence of infection, and 15-55 percent, with a median of 34 percent, received other diagnoses.

    Delayed diagnosis, short or incomplete treatment and a severe start all raise the risk of PTLDS. No treatment is proven. Prolonged antibiotics failed in placebo-controlled trials and carry the risk of serious, sometimes deadly complications. Care resembles the management of fibromyalgia or ME/CFS, and a 2023 review found that PTLDS and ME/CFS share similar pathogenesis despite different infectious origins.

  • An estimated 476,000 people a year are diagnosed and treated for Lyme disease in the United States, a number probably inflated by overdiagnosis. Europe sees over 200,000 a year. Cases are highest among 10- to 19-year-olds, and males and females are affected about equally.

    The CDC began national surveillance in 1991. About 99 percent of reported American cases fall in just five geographic areas, including New England and the Mid-Atlantic. In the ten states where the disease is most common, the average in 2005 was 31.6 cases per 100,000 people. The CDC prizes its surveillance data for "uniformity, simplicity, and timeliness," while admitting limits. Cases are likely under-reported where the disease is common and over-reported where it is rare. They are also logged by county of residence rather than where the infection happened.

    North of the border, the range of Lyme-carrying ticks has spread from a limited area of Ontario to parts of Quebec, Manitoba, New Brunswick, Nova Scotia, Saskatchewan, Alberta and British Columbia. A model by Leighton and colleagues in 2012 predicted spread into Canada at 46 km a year. A 2005 study projected a 213 percent increase in suitable tick habitat by 2080. Climate change is widely suspected of helping ticks, but tick-borne disease systems are complex, and other drivers are hard to rule out. A 2008 review found that forest was the only variable consistently linked with higher risk.

    In Europe, infected ticks are most common in central Europe, particularly Slovenia and Austria. Iceland records only 6 or 7 cases a year, and none had a definite Icelandic origin. The United Kingdom recorded 68 cases across the UK and Ireland in 1986, when voluntary reporting began. Confirmed cases reached 973 in 2009 and 953 in 2010. England's Health Protection Agency estimated 2,000-3,000 cases a year in England and Wales. A 1989 report found that 25 percent of forestry workers in the New Forest were seropositive. Infected ticks have even been found in London parks.

    Elsewhere, the picture is patchy. Brazil does not consider Lyme disease endemic, but a Lyme-like illness called Baggio-Yoshinari syndrome was first reported there in 1992, in Cotia, in the state of Sao Paulo. A 2024 analysis found the evidence tying it to Borrelia was lacking. Two cases have been reported in Kenya. Infected ticks are turning up more often in Japan, northwest China, Nepal, Thailand and far eastern Russia. Australia is not considered endemic, though researchers continue to investigate a set of debilitating symptoms attributed to ticks there, known as DSCATT.

  • In the northeastern United States, an estimated 69 percent of tick bites happen at home. Another 11 percent occur at schools or camps, 9 percent in parks, 4 percent at work and 3 percent while hunting. Yard work, gardening and letting roaming pets indoors all bring ticks close. Nymphs wait on low leaves and grasses with forelegs outstretched and cling to whatever brushes past. Tick density is highest in woodland, about half as high at the unmaintained edge of a lawn, and roughly 30 times lower on the lawn itself.

    A 0.5 percent permethrin solution on clothes, shoes and camping gear, recommended by the CDC, is highly toxic to ticks. Nymphs crawling on treated fabric for as few as 10-20 seconds become irritated and fall off or die. Treated shoes and socks cut bites from nymphs by 74 times. Treated military and outdoor-worker uniforms reduced bite cases by 80-95 percent. Permethrin is never for skin, underwear or cats. For skin, the EPA recommends repellents including DEET, picaridin, IR3535 and oil of lemon eucalyptus. In tests against ticks, 20 percent picaridin may last 8 hours, against 5-6 hours for 55-98.11 percent DEET.

    After coming indoors, ten minutes in a hot dryer kills ticks on clothing, while washing alone does not. Checking the body is vital, especially the armpits, the back of the knee and the bellybutton. A day or two after attaching, a feeding nymph looks like a small blood blister. The CDC advises grasping the tick with fine-tipped tweezers between skin and tick and pulling straight out without twisting. It warns against nail polish, petroleum jelly and heat. In Australia, where a paralysis tick is common, a clinical immunology society advises against tweezers because an allergic person could suffer anaphylaxis. It suggests spraying the tick so it freezes and drops off, or tying a slow overhand knot with dental floss.

    It takes between 36 and 48 hours of attachment for the bacteria to move from the tick into its saliva. In North America, the risk is small if the tick is removed within 36 hours. If a likely infected deer tick has been attached that long or is engorged, one dose of doxycycline within 72 hours may help. About 50 bitten people would need that dose to prevent a single rash.

    Yard design matters too. A 3-ft-wide barrier of rock or woodchips between lawn and woods discourages ticks, and a sunny tick-safe zone at least 9 ft beyond it should hold patios and playgrounds. An 8-ft fence can keep deer out.

    Deer have been a target. Cases fell after deer were eradicated on Monhegan island in Maine, and after deer control in Mumford Cove, Connecticut. Advocates suggest 8 to 10 deer per square mile, compared with 60 or more where Lyme rates are highest. Studies in Massachusetts and New Jersey saw no significant drop in ticks, so culling remains debated.

    A human vaccine called LYMERix was produced but discontinued in 2002 because of insufficient demand. At the time of the latest summary, no human vaccine was available. Several vaccines already exist for dogs.

Updated

Common questions

What is Lyme disease and how is it caused?

Lyme disease is a tick-borne illness caused by Borrelia bacteria and transmitted by blood-feeding ticks of the genus Ixodes. It is the most common disease spread by ticks in the Northern Hemisphere.

What does the Lyme disease rash look like?

The Lyme disease rash, called erythema migrans, is usually circular or oval and red or bluish. It expands about 2-3 cm per day to a diameter of 5-70 cm, and a bull's-eye pattern appears in about 79 percent of European cases but only 19 percent of cases in endemic areas of the United States.

How is Lyme disease diagnosed?

A rash plus tick exposure within 30 days is enough for diagnosis, with no laboratory test needed. Otherwise the CDC recommends a two-tiered antibody test, an ELISA followed by a Western blot.

How is Lyme disease treated?

Doxycycline by mouth is the usual first choice for early localized Lyme disease, with courses of 7-14 days. Intravenous ceftriaxone is recommended for heart, joint or nervous system involvement, and treatment beyond 28 days is not recommended.

What is post-treatment Lyme disease syndrome?

Post-treatment Lyme disease syndrome, or PTLDS, is chronic pain, fatigue or cognitive impairment that persists after treatment in 5-20 percent of people who contract Lyme disease. Its cause is unknown, and prolonged antibiotics have been ineffective in placebo-controlled trials.

How long must a tick be attached to transmit Lyme disease?

It takes between 36 and 48 hours of attachment for Lyme bacteria to travel from the tick into its saliva. In North America the risk is small if the tick is removed within 36 hours.

Is there a vaccine for Lyme disease?

A human vaccine called LYMERix was produced but discontinued in 2002 because of insufficient demand. Several vaccines exist for dogs.

All sources

347 references cited across the entry

  1. 4JournalEstimating the Frequency of Lyme Disease Diagnoses, United States, 2010–2018Kugeler KJ, Schwartz AM, Delorey MJ, Mead PS, Hinckley AF — February 2021
  2. 5JournalComparison of Lyme Disease in the United States and EuropeMarques AR, Strle F, Wormser GP — August 2021
  3. 6JournalHost association of Borrelia burgdorferi sensu lato: A reviewWolcott KA, Margos G, Fingerle V, Becker NS — September 2021
  4. 14Lyme disease rashes and look-alikesCenters for Disease Control and Prevention — December 21, 2018
  5. 15Lyme disease: erythema migransNational Institute for Health and Care Excellence
  6. 16JournalDelayed Diagnosis of Locally Acquired Lyme Disease, Central North Carolina, USA.RM Boyce et al. — March 2024
  7. 17JournalAnnular Lesions: Diagnosis and Treatment.KP Trayes et al. — 1 September 2018
  8. 18JournalDoes this patient have erythema migrans?Tibbles CD, Edlow JA — June 2007
  9. 20JournalEFNS guidelines on the diagnosis and management of European Lyme neuroborreliosisMygland A, Ljøstad U, Fingerle V, Rupprecht T, Schmutzhard E, Steiner I — January 2010
  10. 21JournalNeurological findings of Lyme diseasePachner AR, Steere AC — July 1984
  11. 22JournalOtolaryngologic aspects of Lyme diseaseMoscatello AL, Worden DL, Nadelman RB, Wormser G, Lucente F — June 1991
  12. 23JournalCourse and Outcome of Early European Lyme Neuroborreliosis (Bannwarth Syndrome): Clinical and Laboratory FindingsOgrinc K, Lusa L, Lotrič-Furlan S, Bogovič P, Stupica D, Cerar T, Ružić-Sabljić E, Strle F — August 2016
  13. 24JournalNervous system Lyme diseaseHalperin JJ — September 2010
  14. 25JournalLyme carditisFish AE, Pride YB, Pinto DS — June 2008
  15. 26JournalLyme borreliosisStanek G, Wormser GP, Gray J, Strle F — February 2012
  16. 27JournalPediatric unilateral knee swelling: a case report of a complicated differential diagnosis and often overlooked causeGuardado KE, Sergent S — January 2022
  17. 28JournalA critical appraisal of the mild axonal peripheral neuropathy of late neurologic Lyme diseaseWormser GP, Strle F, Shapiro ED, Dattwyler RJ, Auwaerter PG — February 2017
  18. 29JournalDiagnosis and treatment of Lyme diseaseBratton RL, Whiteside JW, Hovan MJ, Engle RL, Edwards FD — May 2008
  19. 30JournalRecent discoveries and advancements in research on the Lyme disease spirochete Borrelia burgdorferiWinslow C, Coburn J — 2019
  20. 32JournalEmerging borreliae – Expanding beyond Lyme borreliosisCutler SJ, Ruzic-Sabljic E, Potkonjak A — February 2017
  21. 34JournalLyme Disease: What the Wilderness Provider Needs to KnowJoseph D. Forrester et al. — 1 December 2015
  22. 35BookBaron's Medical MicrobiologyJohnson RC — Univ of Texas Medical Branch — 1996
  23. 36JournalLyme borreliosisSteere AC, Strle F, Wormser GP, Hu LT, Branda JA, Hovius JW, Li X, Mead PS — December 2016
  24. 38JournalIdentification of a novel pathogenic Borrelia species causing Lyme borreliosis with unusually high spirochaetaemia: a descriptive studyPritt BS, Mead PS, Johnson DK, Neitzel DF, Respicio-Kingry LB, Davis JP, Schiffman E, Sloan LM, Schriefer ME, Replogle AJ, Paskewitz SM, Ray JA, Bjork J, Steward CR, Deedon A, Lee X, Kingry LC, Miller TK, Feist MA, Theel ES, Patel R, Irish CL, Petersen JM — May 2016
  25. 39JournalClinical practice. Lyme diseaseShapiro ED — May 2014
  26. 402005 Fact Sheet, Prevent Tick Bites: Prevent Lyme DiseaseSmith-Fiola D, Hamilton GC — Rutgers University, Rutgers Cooperative Research & Extension, New Jersey Agricultural Experiment Station — March 2005
  27. 43JournalPathogen transmission in relation to duration of attachment by Ixodes scapularis ticksLars Eisen — 6 March 2018
  28. 44JournalLyme borreliosis: a review of data on transmission time after tick attachmentMichael J. Cook — 6 May 2015
  29. 46How Lyme Disease Spreads24 September 2024
  30. 48JournalClinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 Guidelines for the Prevention, Diagnosis and Treatment of Lyme DiseaseLantos PM, Rumbaugh J, Bockenstedt LK, Falck-Ytter YT, Aguero-Rosenfeld ME, Auwaerter PG, Baldwin K, Bannuru RR, Belani KK, Bowie WR, Branda JA, Clifford DB, DiMario FJ, Halperin JJ, Krause PJ, Lavergne V, Liang MH, Meissner HC, Nigrovic LE, Nocton JJ, Osani MC, Pruitt AA, Rips J, Rosenfeld LE, Savoy ML, Sood SK, Steere AC, Strle F, Sundel R, Tsao J, Vaysbrot EE, Wormser GP, Zemel LS — January 2021
  31. 50JournalPathogenicity and virulence of Borrelia burgdorferiStrnad M, Rudenko N, Rego RO — December 2023
  32. 51Lyme Disease Data and surveillanceCenters for Disease Control and Prevention — 5 February 2019
  33. 52Lyme Disease risk areas mapGovernment of Canada — 27 January 2015
  34. 53JournalDiagnostic challenges of early Lyme disease: lessons from a community case seriesAucott J, Morrison C, Munoz B, Rowe PC, Schwarzwalder A, West SK — June 2009
  35. 54Lyme diseaseNational Institute for Health and Care Excellence — 11 April 2018
  36. 55JournalDiagnosis of lyme diseaseDePietropaolo DL, Powers JH, Gill JM, Foy AJ — July 2005
  37. 57JournalDetection of antigens in urine of mice and humans infected with Borrelia burgdorferi, etiologic agent of Lyme diseaseHyde FW, Johnson RC, White TJ, Shelburne CE — January 1989
  38. 58JournalThe use of Nanotrap particles for biodefense and emerging infectious disease diagnosticsShafagati N, Patanarut A, Luchini A, Lundberg L, Bailey C, Petricoin E, Liotta L, Narayanan A, Lepene B, Kehn-Hall K — July 2014
  39. 59JournalNeuropsychological functioning in chronic Lyme diseaseWestervelt HJ, McCaffrey RJ — September 2002
  40. 60JournalRecommendations for the management of herpes zosterDworkin RH, Johnson RW, Breuer J, Gnann JW, Levin MJ, Backonja M, Betts RF, Gershon AA, Haanpaa ML, McKendrick MW, Nurmikko TJ, Oaklander AL, Oxman MN, Pavan-Langston D, Petersen KL, Rowbotham MC, Schmader KE, Stacey BR, Tyring SK, van Wijck AJ, Wallace MS, Wassilew SW, Whitley RJ — January 2007
  41. 61JournalChronic Lyme disease: misconceptions and challenges for patient managementHalperin JJ — May 2015
  42. 62JournalLumbosacral radiculopathyTarulli AW, Raynor EM — May 2007
  43. 63JournalTwo-tiered antibody testing for Lyme disease with use of 2 enzyme immunoassays, a whole-cell sonicate enzyme immunoassay followed by a VlsE C6 peptide enzyme immunoassayBranda JA, Linskey K, Kim YA, Steere AC, Ferraro MJ — September 2011
  44. 64JournalRandomized Trial of Longer-Term Therapy for Symptoms Attributed to Lyme DiseaseBerende A, ter Hofstede HJ, Vos FJ, van Middendorp H, Vogelaar ML, Tromp M, van den Hoogen FH, Donders AR, Evers AW, Kullberg BJ — March 2016
  45. 65JournalManaging Peripheral Facial PalsyGarro A, Nigrovic LE — May 2018
  46. 66OTC Drops: Telling the Tears ApartStephenson M — Jobson Medical Information LLC — 4 October 2012
  47. 67JournalDiagnosis and treatment of Lyme arthritisArvikar SL, Steere AC — June 2015
  48. 68JournalDuration of antibiotic therapy for early Lyme disease. A randomized, double-blind, placebo-controlled trialWormser GP, Ramanathan R, Nowakowski J, McKenna D, Holmgren D, Visintainer P, Dornbush R, Singh B, Nadelman RB — May 2003
  49. 69JournalTreatment of erythema migrans with doxycycline for 10 days versus 15 daysStupica D, Lusa L, Ruzić-Sabljić E, Cerar T, Strle F — August 2012
  50. 70JournalCeftriaxone compared with doxycycline for the treatment of acute disseminated Lyme diseaseDattwyler RJ, Luft BJ, Kunkel MJ, Finkel MF, Wormser GP, Rush TJ, Grunwaldt E, Agger WA, Franklin M, Oswald D, Cockey L, Maladorno D — July 1997
  51. 71JournalChronic symptoms are common in patients with neuroborreliosis – a questionnaire follow-up studyVrethem M, Hellblom L, Widlund M, Ahl M, Danielsson O, Ernerudh J, Forsberg P — October 2002
  52. 72Journal5-y Follow-up study of patients with neuroborreliosisBerglund J, Stjernberg L, Ornstein K, Tykesson-Joelsson K, Walter H — 2002
  53. 73JournalFacial paralysis in Lyme diseaseClark JR, Carlson RD, Sasaki CT, Pachner AR, Steere AC — November 1985
  54. 74JournalSuccessful oral doxycycline treatment of Lyme disease-associated facial palsy and meningitisDotevall L, Hagberg L — March 1999
  55. 75JournalEvaluation of study patients with Lyme disease, 10-20-year follow-upKalish RA, Kaplan RF, Taylor E, Jones-Woodward L, Workman K, Steere AC — February 2001
  56. 76JournalSteroid use in Lyme disease-associated facial palsy is associated with worse long-term outcomesJowett N, Gaudin RA, Banks CA, Hadlock TA — June 2017
  57. 77JournalDifferentiation of reinfection from relapse in recurrent Lyme diseaseNadelman RB, Hanincová K, Mukherjee P, Liveris D, Nowakowski J, McKenna D, Brisson D, Cooper D, Bittker S, Madison G, Holmgren D, Schwartz I, Wormser GP — November 2012
  58. 78JournalPosttreatment Lyme disease syndrome and myalgic encephalomyelitis/chronic fatigue syndrome: A systematic review and comparison of pathogenesisBai NA, Richardson CS — September 2023
  59. 79JournalWhat Makes It Tick: Exploring the Mechanisms of Post-treatment Lyme Disease SyndromeKate E. Wester et al. — 5 July 2024
  60. 80JournalPersistent Symptoms After Treatment of Lyme DiseaseAdriana Marques — September 2022
  61. 81Post-Treatment Lyme Disease SyndromeCDC — 3 November 2016
  62. 82JournalPost-treatment Lyme Disease as a Model for Persistent Symptoms in Lyme DiseaseAlison W. Rebman et al. — 2020
  63. 83JournalPosttreatment Lyme disease syndrome and myalgic encephalomyelitis/chronic fatigue syndrome: A systematic review and comparison of pathogenesisNatalie A. Bai et al. — 5 September 2023
  64. 85JournalThe Clinical, Symptom, and Quality-of-Life Characterization of a Well-Defined Group of Patients with Posttreatment Lyme Disease SyndromeA. W. Rebman et al. — 13 December 2017
  65. 87BookLyme disease: Global Status 2014 EditionBerger S — GIDEON Informatics Inc — 2014
  66. 89JournalImpact of prior and projected climate change on US Lyme disease incidenceLisa I. Couper et al. — 5 February 2021
  67. 90Lyme disease bites as ticks gain ground in USAndrew Jack — 29 April 2024
  68. 91JournalThe Impacts of Climate Change on Ticks and Tick-Borne Disease RiskGilbert L — January 2021
  69. 92JournalEffect of Climate Change on Lyme Disease Risk in North AmericaBrownstein JS, Holford TR, Fish D — March 2005
  70. 93JournalSpatial dynamics of lyme disease: a reviewKillilea ME, Swei A, Lane RS, Briggs CJ, Ostfeld RS — June 2008
  71. 97STARI or Lyme?19 November 2018
  72. 98JournalLyme disease in Western Europe: an emerging problem? A systematic reviewVandekerckhove O, De Buck E, Van Wijngaerden E — June 2021
  73. 99JournalLyme disease in Iceland – Epidemiology from 2011 to 2015Vigfusson HB, Hardarson HS, Ludviksson BR, Gudlaugsson O — February 2019
  74. 100JournalTick hazard in the South Downs National Park (UK): species, distribution, key locations for future interventions, site density, habitatsJo Middleton et al. — 2024-06-12
  75. 101JournalLyme borreliosis in Brazil: a critical review on the Baggio–Yoshinari syndrome (Brazilian Lyme-like disease)Marcelo B. Labruna et al. — 4 November 2024
  76. 102Case of the MonthDecember 2015
  77. 103JournalHuman Tick-Borne Diseases in AustraliaDehhaghi M, Kazemi Shariat Panahi H, Holmes EC, Hudson BJ, Schloeffel R, Guillemin GJ — 2019
  78. 104JournalMetatranscriptomic profiling reveals diverse tick-borne bacteria, protozoans and viruses in ticks and wildlife from AustraliaGofton AW, Blasdell KR, Taylor C, Banks PB, Michie M, Roy-Dufresne E, Poldy J, Wang J, Dunn M, Tachedjian M, Smith I — September 2022
  79. 105JournalThe Troublesome Ticks Research Protocol: Developing a Comprehensive, Multidiscipline Research Plan for Investigating Human Tick-Associated Disease in AustraliaBarbosa AD, Long M, Lee W, Austen JM, Cunneen M, Ratchford A, Burns B, Kumarasinghe P, Ben-Othman R, Kollmann TR, Stewart CR, Beaman M, Parry R, Hall R, Tabor A, O'Donovan J, Faddy HM, Collins M, Cheng AC, Stenos J, Graves S, Oskam CL, Ryan UM, Irwin PJ — November 2022
  80. 106Preventing tick bites on peopleCenters for Disease Control and Prevention — 8 March 2019
  81. 107About ticks – preventative measuresCompanion Vector-Borne Diseases
  82. 108JournalCritical Evaluation of the Linkage Between Tick-Based Risk Measures and the Occurrence of Lyme Disease CasesEisen L, Eisen RJ — September 2016
  83. 110Protection against Mosquitoes, Ticks, & Other ArthropodsCenters for Disease Control and Prevention
  84. 111JournalBioassays to evaluate non-contact spatial repellency, contact irritancy, and acute toxicity of permethrin-treated clothing against nymphal Ixodes scapularis ticksEisen L, Rose D, Prose R, Breuner NE, Dolan MC, Thompson K, Connally N — October 2017
  85. 112JournalTick bite protection with permethrin-treated summer-weight clothingMiller NJ, Rainone EE, Dyer MC, González ML, Mather TN — March 2011
  86. 113Tips to prevent tick bytesEnvironmental Protection Agency — 15 July 2013
  87. 114JournalPermethrin toxicity in cats: a retrospective study of 20 casesDymond NL, Swift IM — June 2008
  88. 115Repellents: protection against mosquitoes, ticks and other arthropodsEnvironmental Protection Agency — 9 July 2013
  89. 116JournalInsect repellents: An updated review for the clinicianNguyen QD, Vu MN, Hebert AA — January 2023
  90. 117Tick management handbook (rev. ed.)Stafford KC — Connecticut Agricultural Experiment Station — 2007
  91. 118Tick removal and testingCenters for Disease Control and Prevention — 22 April 2019
  92. 120JournalDeath of unknown origin in alpine medicineRöggla G — 2002
  93. 121JournalEffective tick removal with a fishing line knotGhirga G, Ghirga P — September 2010
  94. 122Preventing tick bites in the yardCenters for Disease Control and Prevention — 8 March 2019
  95. 126JournalDeer, predators, and the emergence of Lyme diseaseTaal Levi et al. — 2012-07-03
  96. 128JournalEffect of deer reduction on abundance of the deer tick (Ixodes dammini).Mark L Wilson et al. — 1984
  97. 129JournalEffects of Reduced Deer Density on the Abundance ofIxodes scapularis(Acari: Ixodidae) and Lyme Disease Incidence in a Northern New Jersey Endemic AreaRobert A. Jordan et al. — 2007-09-01
  98. 130JournalWill Culling White-Tailed Deer Prevent Lyme Disease?K. J. Kugeler et al. — 2016
  99. 132JournalWhite-Tailed Deer Serum Kills the Lyme Disease Spirochete, Borrelia burgdorferiPatrick Pearson et al. — May 2023
  100. 133JournalEmerging tick-borne pathogens of public health importance: a mini-reviewRochlin I, Toledo A — June 2020
  101. 134JournalImportance of ticks and their chemical and immunological control in livestockRajput ZI, Hu SH, Chen WJ, Arijo AG, Xiao CW — November 2006
  102. 135JournalEuropean reservoir hosts of Borrelia burgdorferi sensu latoGern L, Estrada-Peña A, Frandsen F, Gray JS, Jaenson TG, Jongejan F, Kahl O, Korenberg E, Mehl R, Nuttall PA — March 1998
  103. 136JournalIncompetence of roe deer as reservoirs of the Lyme borreliosis spirocheteJaenson TG, Tälleklint L — September 1992
  104. 137JournalTransmission of Borrelia burgdorferi s.l. from mammal reservoirs to the primary vector of Lyme borreliosis, Ixodes ricinus (Acari: Ixodidae), in SwedenTälleklint L, Jaenson TG — November 1994
  105. 138JournalHost and pathogen DNA identification in blood meals of nymphal Ixodes ricinus ticks from forest parks and rural forests of PolandWodecka B, Rymaszewska A, Skotarczak B — April 2014
  106. 139JournalDetection of tick-borne pathogens in roe deer (Capreolus capreolus), in questing ticks (Ixodes ricinus), and in ticks infesting roe deer in southern GermanyOverzier E, Pfister K, Herb I, Mahling M, Böck G, Silaghi C — June 2013
  107. 140Lyme disease vaccineCenters for Disease Control and Prevention — 2022-08-11
  108. 141JournalHuman and Veterinary Vaccines for Lyme DiseaseO'Bier NS, Hatke AL, Camire AC, Marconi RT — 2021
  109. 142JournalVaccines against Lyme disease: What happened and what lessons can we learn?Poland GA — February 2011
  110. 143JournalThe rise and fall of the lyme disease vaccines: a cautionary tale for risk interventions in American medicine and public healthAronowitz RA — June 2012
  111. 148NewsLyme disease vaccine shows 70 percent efficacy, Pfizer saysCarolyn Y. Johnson — 23 March 2026
  112. 149NewsLyme disease vaccine 70 percent effective: PfizerAshleigh Fields — 23 March 2026
  113. 152JournalmRNA vaccination induces tick resistance and prevents transmission of the Lyme disease agentSajid A, Matias J, Arora G, Kurokawa C, DePonte K, Tang X, Lynn G, Wu MJ, Pal U, Strank NO, Pardi N, Narasimhan S, Weissman D, Fikrig E — November 2021
  114. 153JournalA Lyme disease mRNA vaccine targeting Borrelia burgdorferi OspA induces strong immune responses and prevents transmission in miceDjamel Tahir et al. — June 2025
  115. 154JournalDevelopment of an mRNA-lipid nanoparticle vaccine against Lyme diseaseMatthew Pine et al. — 6 September 2023
  116. 155BookThe Widening Circle: A Lyme Disease Pioneer Tells Her StoryMurray P — St. Martin's Press
  117. 158JournalNew insights into the Tyrolean Iceman's origin and phenotype as inferred by whole-genome sequencingAndreas Keller et al. — 28 February 2012
  118. 159JournalSuccessful treatment of erythema migrans AfzeliusEinar Hollström — 1951
  119. 163BookInfectious disease epidemiology: theory and practiceWilliams C — Jones and Bartlett Publishers — 2007
  120. 165JournalLyme disease: a rigorous review of diagnostic criteria and treatmentBorchers AT, Keen CL, Huntley AC, Gershwin ME — February 2015
  121. 166NewsLyme Disease Pioneer Stephen Malawista DiesWeir W — 19 September 2013
  122. 167JournalDeer, predators, and the emergence of Lyme diseaseT Levi et al. — 2012
  123. 168NewsWilly Burgdorfer – obituary1 December 2014
  124. 169JournalLow probability of a dilution effect for Lyme borreliosis in Belgian forestsRuyts SC, Landuyt D, Ampoorter E, Heylen D, Ehrmann S, Coipan EC, Matthysen E, Sprong H, Verheyen K — July 2018
  125. 170A Review of Under Our Skin, A Cult ClassicMacBeth B — 8 April 2019
  126. 172The mysterious lab off New York's shoreAdam Dunn — 2009-04-02
  127. 173JournalBook ReviewsReid Kirby
  128. 175NewsRFK Jr Senate hearing resurrects Lyme disease bioweapon conspiracy theoryDaniel Patrick Galgano — 5 February 2025
  129. 177JournalFirst report of Lyme borreliosis leading to cardiac bradydysrhythmia in two catsTørnqvist-Johnsen C, Dickson SA, Rolph K, Palermo V, Hodgkiss-Geere H, Gilmore P, Gunn-Moore DA — 2020
  130. 178JournalLyme borreliosis in cattle and horses: a review of the literatureJ. L. Parker et al. — 1992
  131. 179JournalRetrospective Evaluation of Horses Diagnosed with Neuroborreliosis on Postmortem Examination: 16 Cases (2004–2015)L. K. Johnstone et al. — 2016
  132. 180JournalLyme borreliosis in the horse: A mini-reviewJ. H. Van der Kolk — 2016
  133. 181JournalArthritis and panuveitis as manifestations of Borrelia burgdorferi infection in a Wisconsin ponyE. C. Burgess et al. — 1986
  134. 182JournalLameness associated with Borrelia burgdorferi infection in the horseA. Browning et al. — 1993
  135. 183JournalSurvey on the subject of equine Lyme borreliosisY Gall et al. — 2006
  136. 184JournalEncephalitis associated with Borrelia burgdorferi infection in a horseE. C. Burgess et al. — 1987
  137. 185JournalA possible case of Lyme borreliosis in a horse in the UKC. N. Hahn et al. — 1996
  138. 186JournalMeningitis, cranial neuritis, and radiculoneuritis associated with Borrelia burgdorferi infection in a horseF. M. James et al. — 2010
  139. 187JournalBorrelia burgdorferi Infection and Lyme Disease in North American Horses: A Consensus StatementT. J. Divers et al. — 2018
  140. 188JournalSeroprevalence of antibodies to Borrelia burgdorferi in a population of horses in central TexasN. D. Cohen et al. — 1992
  141. 189JournalThe prevalence of antibodies against Borrelia burgdorferi found in horses residing in the northwestern United StatesK. B. Metcalf et al. — 2008
  142. 190JournalSeroprevalence of Borrelia burgdorferi sensu lato and Anaplasma phagocytophilum Infections in German HorsesGehlen H, Inerle K, Bartel A, Stöckle SD, Ulrich S, Briese B, Straubinger RK — June 2023
  143. 191JournalStudy of intragastric administration of doxycycline: pharmacokinetics including body fluid, endometrial and minimum inhibitory concentrationsJ. E. Bryant et al. — 2000
  144. 192JournalAntibiotic treatment of experimentally Borrelia burgdorferi-infected poniesY. F. Chang et al. — 2005
  145. 193JournalPharmacokinetics and distribution of minocycline in mature horses after oral administration of multiple doses and comparison with minimum inhibitory concentrationsL. V. Schnabel et al. — 2012
  146. 194JournalA case of Borrelia-associated cutaneous pseudolymphoma in a horseK. P. Sears et al. — 2012
  147. 195JournalChanges in Borrelia burgdorferi ELISA antibody over time in both antibiotic treated and untreated horsesT. J. Divers et al. — 2012
  148. 196JournalVaccination of horses with Lyme vaccines for dogs induces short-lasting antibody responsesC. Guarino et al. — 2017
  149. 197JournalVaccination against Lyme Disease with recombinant Borrelia burgdorferi outer-surface protein A (rOspA) in horsesY. F. Chang et al. — 1999
  150. 198JournalA study with a commercial vaccine against Lyme borreliosis in horses using two different vaccination schedules: Characterization of the humoral immune responseJ. M. Knödlseder et al. — 2019
  151. 199JournalVerhandlungen der dermatologischen Gesellschaft zu StockholmMarcus K — 1910
  152. 200JournalZur Frage der Follikel- und Keimzentrenbildung in der HautBurckhardt JL — 1911
  153. 201JournalPenicillin therapy of lymphocytomaBianchi GE — 1950
  154. 202BookDermatologyBolognia JL, Jorizzo JL, Rapini RP — Mosby — 2007
  155. 203JournalDiscovery of the Lyme disease spirochete and its relation to tick vectorsBurgdorfer W — 1984
  156. 204JournalLyme disease-a tick-borne spirochetosis?Burgdorfer W, Barbour AG, Hayes SF, Benach JL, Grunwaldt E, Davis JP — June 1982
  157. 205CDC Lyme disease FAQ8 January 2021
  158. 206JournalMolecular mimicry to Borrelia burgdorferi: pathway to autoimmunity?Bolz DD, Weis JJ — August 2004
  159. 207JournalRole of serology in the diagnosis of Lyme diseaseBrown SL, Hansen SL, Langone JJ — July 1999
  160. 208Lyme disease diagnosisCenters for Disease Control and Prevention (CDC) — 7 October 2008
  161. 209JournalLyme borreliosis: detecting the great imitatorBurdash N, Fernandes J — June 1991
  162. 210JournalBorrelia species in host-seeking ticks and small mammals in northern FloridaClark K — November 2004
  163. 211JournalSurveillance for Lyme disease--United States, 1992-2006Bacon RM, Kugeler KJ, Mead PS — October 2008
  164. 212JournalDetection of Borrelia burgdorferi-specific antigen in antibody-negative cerebrospinal fluid in neurologic Lyme diseaseCoyle PK, Schutzer SE, Deng Z, Krupp LB, Belman AL, Benach JL, Luft BJ — November 1995
  165. 213NewsLyme disease risk from dogs 'higher than thought'Roberts M — 24 January 2012
  166. 214JournalAmoxycillin plus probenecid versus doxycycline for treatment of erythema migrans borreliosisDattwyler RJ, Volkman DJ, Conaty SM, Platkin SP, Luft BJ — December 1990
  167. 215JournalThe geographical distribution of tick bites and erythema migrans in general practice in The Netherlandsde Mik EL, van Pelt W, Docters-van Leeuwen BD, van der Veen A, Schellekens JF, Borgdorff MW — April 1997
  168. 216JournalThe Lyme vaccine: a cautionary taleNigrovic LE, Thompson KM — January 2007
  169. 217JournalSituation de la borreliose de Lyme au MaghrebBouattour A, Ghorbel A, Chabchoub A, Postic D — 2004
  170. 218BookDisguised as the devil: how Lyme disease created witches and changed historyDrymon M. M. — Wythe Avenue Press — 2008
  171. 219Lyme DiseaseBrooks WC — Veterinary Information Network
  172. 220Concern about rise in Lyme disease casesLyme Disease Action — 15 December 2011
  173. 223Reported Lyme disease cases by state, 2000–2010CDC — Centers for Disease Control and Prevention (CDC) — 4 January 2012
  174. 224Lyme Disease DataCenters for Disease Control and Prevention (CDC)
  175. 225JournalThe role of infections in autoimmune diseaseErcolini AM, Miller SD — January 2009
  176. 226JournalNervous system Lyme diseaseHalperin JJ — June 2008
  177. 227JournalErythema chronicum migrans AfzeliiHellerström S — 1930
  178. 228Zoonoses report UK 2009DEFRA — 24 January 2011
  179. 229JournalPhylogeography of Borrelia burgdorferi in the eastern United States reflects multiple independent Lyme disease emergence eventsHoen AG, Margos G, Bent SJ, Diuk-Wasser MA, Barbour A, Kurtenbach K, Fish D — September 2009
  180. 230JournalTick-host-pathogen interactions in Lyme borreliosisHovius JW, van Dam AP, Fikrig E — September 2007
  181. 231JournalReservoir Role of Lizard Psammodromus algirus in Transmission Cycle of Borrelia burgdorferi Sensu Lato (Spirochaetaceae) in TunisiaNajla Dsouli et al. — July 2006
  182. 232JournalLyme borreliosis--problems of serological diagnosisHofmann H — 1996
  183. 233JournalLyme neuroborreliosis: manifestations of a rapidly emerging zoonosisHildenbrand P, Craven DE, Jones R, Nemeskal P — June 2009
  184. 234JournalThe clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of AmericaWormser GP, Dattwyler RJ, Shapiro ED, Halperin JJ, Steere AC, Klempner MS, Krause PJ, Bakken JS, Strle F, Stanek G, Bockenstedt L, Fish D, Dumler JS, Nadelman RB — November 2006
  185. 235JournalFatal adult respiratory distress syndrome in a patient with Lyme diseaseKirsch M, Ruben FL, Steere AC, Duray PH, Norden CW, Winkelstein A — May 1988
  186. 236JournalLyme disease--a new disease in southern Africa?Fivaz BH, Petney TN — September 1989
  187. 237Lyme Disease Fact SheetPhac-aspc.gc.ca — 4 July 2012
  188. 239BookTick Management HandbookStafford KC — Connecticut Agricultural Experiment Station and Connecticut Department of Public Health — 2004
  189. 240JournalBorreliacidal activity of saliva of the tick Amblyomma americanumLedin KE, Zeidner NS, Ribeiro JM, Biggerstaff BJ, Dolan MC, Dietrich G, Vredevoe L, Piesman J — March 2005
  190. 241Ticks and Their ControlHahn J — Regents of the University of Minnesota
  191. 242JournalSpirochaetes in aetiologically obscure diseasesLennhoff C — 1948
  192. 243Lyme Disease11 November 1991
  193. 244JournalTick-borne encephalitis in Sweden and climate changeLindgren E, Gustafson R — July 2001
  194. 245Lyme Disease3 February 1997
  195. 246JournalNew chemotherapeutic approaches in the treatment of Lyme borreliosisLuft BJ, Volkman DJ, Halperin JJ, Dattwyler RJ — 1988
  196. 247JournalSeasonal abundance of Ornithodoros (O.) savignyi and prevalence of infection with Borrelia spirochetes in EgyptHelmy N — August 2000
  197. 248JournalEmerging or re-emerging bacterial zoonotic diseases: bartonellosis, leptospirosis, Lyme borreliosis, plagueHiggins R — August 2004
  198. 250Press releaseTick Lyme disease off your holiday listHealth Protection Agency — 14 April 2011
  199. 252JournalErythema Chronicum Migrans and 'Lyme Arthritis'Gerald W. Hazard et al. — 22 November 1976
  200. 253JournalSTARI, or Masters disease: Lone Star tick-vectored Lyme-like illnessMasters EJ, Grigery CN, Masters RW — June 2008
  201. 254BookManaging Urban Deer in ConnecticutConnecticut Department of Environmental Protection – Wildlife Division — June 2007
  202. 255JournalDermatological manifestations of Lyme borreliosisMullegger RR — 2004
  203. 256JournalLyme disease: report of two casesJowi JO, Gathua SN — May 2005
  204. 257Glomerular DiseaseThe Merck Veterinary Manual.
  205. 258JournalGlobal warming and infectious diseaseKhasnis AA, Nettleman MD — 2005
  206. 259JournalLyme disease Borrelia species in northeastern China resemble those isolated from far eastern Russia and JapanLi M, Masuzawa T, Takada N, Ishiguro F, Fujita H, Iwaki A, Wang H, Wang J, Kawabata M, Yanagihara Y — July 1998
  207. 260JournalEmerging pattern of Lyme disease in the United Kingdom and Irish RepublicMuhlemann MF, Wright DJ — January 1987
  208. 261The London climate change adaptation strategy - Draft reportGreater London Authority — August 2008
  209. 262Ticks and Humans in British ColumbiaBC Ministry of Agriculture — Agf.gov.bc.ca
  210. 263JournalPredicting the speed of tick invasion: An empirical model of range expansion for the Lyme disease vector Ixodes scapularis in CanadaLeighton PA, Koffi JK, Pelcat Y, Lindsay LR, Ogden NH — 2012
  211. 264JournalLyme disease—United States, 2003–2005Centers for Disease Control and Prevention (CDC) — June 2007
  212. 265JournalDescription of Lyme disease-like syndrome in Brazil. Is it a new tick borne disease or Lyme disease variation?Mantovani E, Costa IP, Gauditano G, Bonoldi VL, Higuchi ML, Yoshinari NH — April 2007
  213. 266JournalThe ecology of infectious disease: effects of host diversity and community composition on Lyme disease riskLoGiudice K, Ostfeld RS, Schmidt KA, Keesing F — January 2003
  214. 267JournalChronic Lyme disease: a reviewMarques A — June 2008
  215. 268MagazineIceman AutopsyHall SS — November 2011
  216. 269JournalLymphocytoma after tick bitePaschoud JM — 1954
  217. 270JournalMolecular mimicry and immune-mediated diseasesOldstone MB — October 1998
  218. 271JournalNeurologic manifestations of Lyme disease, the new "great imitator"Pachner AR — 1989
  219. 272JournalProtection against lyme disease spirochete transmission provided by prompt removal of nymphal Ixodes scapularis (Acari: Ixodidae)Piesman J, Dolan MC — May 2002
  220. 273JournalThe emergence of Lyme disease in CanadaOgden NH, Lindsay LR, Morshed M, Sockett PN, Artsob H — June 2009
  221. 274NewsMontana Lab Tries to Identify Tick-Borne DiseaseRobbins J — 20 May 2003
  222. 275JournalUnhealthy landscapes: Policy recommendations on land use change and infectious disease emergencePatz JA, Daszak P, Tabor GM, Aguirre AA, Pearl M, Epstein J, Wolfe ND, Kilpatrick AM, Foufopoulos J, Molyneux D, Bradley DJ — July 2004
  223. 276JournalA Critical Appraisal of 'Chronic Lyme Disease'Henry M. Feder et al. — 4 October 2007
  224. 277"Chronic Lyme Disease" Fact SheetNational Institute of Allergy and Infectious Diseases — 17 April 2009
  225. 278JournalAsymptomatic infection with Borrelia burgdorferiSteere AC, Sikand VK, Schoen RT, Nowakowski J — August 2003
  226. 279JournalLyme borreliosis (Lyme disease): molecular and cellular pathobiology and prospects for prevention, diagnosis and treatmentAuwaerter PG, Aucott J, Dumler JS — January 2004
  227. 280JournalIdentifying the vector of Lyme diseaseLo Re V, Occi JL, MacGregor RR — April 2004
  228. 281JournalThe emergence of Lyme diseaseSteere AC, Coburn J, Glickstein L — April 2004
  229. 282JournalLyme diseaseSteere AC — July 2001
  230. 283JournalThe roles of birds, lizards, and rodents as hosts for the western black-legged tick Ixodes pacificusEisen L, Eisen RJ, Lane RS — December 2004
  231. 284JournalRefractoriness of the western fence lizard (Sceloporus occidentalis) to the Lyme disease group spirochete Borrelia bissettiiLane RS, Mun J, Eisen L, Eisen RJ — August 2006
  232. 285JournalCoinfections acquired from ixodes ticksSwanson SJ, Neitzel D, Reed KD, Belongia EA — October 2006
  233. 286JournalLyme neuroborreliosis: infection, immunity, and inflammationPachner AR, Steiner I — June 2007
  234. 287JournalBorrelia burgdorferi--traveling incognito?Fikrig E, Narasimhan S — April 2006
  235. 288JournalIncreasing the recruitment of neutrophils to the site of infection dramatically attenuates Borrelia burgdorferi infectivityXu Q, Seemanapalli SV, Reif KE, Brown CR, Liang FT — April 2007
  236. 289JournalHidden in plain sight: Borrelia burgdorferi and the extracellular matrixCabello FC, Godfrey HP, Newman SA — August 2007
  237. 290JournalThe penicillin treatment of acrodermatitis atrophicans chronica (Herxheimer)Thyresson N — 1949
  238. 291JournalFalse-positive results of PCR testing for Lyme diseaseMolloy PJ, Persing DH, Berardi VP — August 2001
  239. 292JournalLyme disease: European perspectiveStanek G, Strle F — June 2008
  240. 293JournalLyme arthritis: pathogenesis, clinical presentation, and managementPuius YA, Kalish RA — June 2008
  241. 294JournalBorrelia bissettii isolates induce pathology in a murine model of diseaseSchneider BS, Schriefer ME, Dietrich G, Dolan MC, Morshed MG, Zeidner NS — October 2008
  242. 295JournalDiagnosis of lyme borreliosisAguero-Rosenfeld ME, Wang G, Schwartz I, Wormser GP — July 2005
  243. 296JournalLyme disease: reviewBiesiada G, Czepiel J, Leśniak MR, Garlicki A, Mach T — December 2012
  244. 297JournalTerrestrial distribution of the Lyme borreliosis agent Borrelia burgdorferi sensu lato in East AsiaMasuzawa T — December 2004
  245. 298JournalDetection of Borrelia bissettii in cardiac valve tissue of a patient with endocarditis and aortic valve stenosis in the Czech RepublicRudenko N, Golovchenko M, Mokrácek A, Piskunová N, Ruzek D, Mallatová N, Grubhoffer L — October 2008
  246. 299JournalBiology of infection with Borrelia burgdorferiTilly K, Rosa PA, Stewart PE — June 2008
  247. 300JournalLyme borreliosis: Europe-wide coordinated surveillance and action needed?Smith R, Takkinen J — June 2006
  248. 302JournalPlasminogen is required for efficient dissemination of B. burgdorferi in ticks and for enhancement of spirochetemia in miceColeman JL, Gebbia JA, Piesman J, Degen JL, Bugge TH, Benach JL — June 1997
  249. 303JournalPerpetuation of the Lyme disease spirochete Borrelia lusitaniae by lizardsRichter D, Matuschka FR — July 2006
  250. 304JournalDissemination and salivary delivery of Lyme disease spirochetes in vector ticks (Acari: Ixodidae)Ribeiro JM, Mather TN, Piesman J, Spielman A — March 1987
  251. 305JournalDetection of Borrelia burgdorferi DNA in lizards from Southern MarylandSwanson KI, Norris DE — 2007
  252. 306JournalThe pathogenesis of lyme neuroborreliosis: from infection to inflammationRupprecht TA, Koedel U, Fingerle V, Pfister HW — 2008
  253. 307JournalBorrelia lusitaniae and green lizards (Lacerta viridis), Karst Region, SlovakiaMajláthová V, Majláth I, Derdáková M, Víchová B, Pet'ko B — December 2006
  254. 308JournalBorrelia lusitaniae in Immature Ixodes ricinus (Acari: Ixodidae) Feeding on Common Wall Lizards in Tuscany, Central ItalyGiuseppina Amore et al. — March 2007
  255. 309JournalPractice parameter: treatment of nervous system Lyme disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of NeurologyHalperin JJ, Shapiro ED, Logigian E, Belman AL, Dotevall L, Wormser GP, Krupp L, Gronseth G, Bever CT — July 2007
  256. 310JournalErythema chronicum migransScrimenti RJ — July 1970
  257. 311JournalThe role of lizards in the ecology of Lyme disease in two endemic zones of the northeastern United StatesGiery ST, Ostfeld RS — June 2007
  258. 312BookSherris Medical MicrobiologyMcGraw Hill — 2004
  259. 313JournalMusculoskeletal and neurologic outcomes in patients with previously treated Lyme diseaseShadick NA, Phillips CB, Sangha O, Logigian EL, Kaplan RF, Wright EA, Fossel AH, Fossel K, Berardi V, Lew RA, Liang MH — December 1999
  260. 314JournalEvidence of Borrelia autoimmunity-induced component of Lyme carditis and arthritisRaveche ES, Schutzer SE, Fernandes H, Bateman H, McCarthy BA, Nickell SP, Cunningham MW — February 2005
  261. 315JournalLong-term outcomes of persons with Lyme diseaseSeltzer EG, Gerber MA, Cartter ML, Freudigman K, Shapiro ED — February 2000
  262. 316JournalDetection of Borrelia burgdorferi DNA by polymerase chain reaction in synovial fluid from patients with Lyme arthritisNocton JJ, Dressler F, Rutledge BJ, Rys PN, Persing DH, Steere AC — January 1994
  263. 317JournalThe expanding Lyme Borrelia complex--clinical significance of genomic species?Stanek G, Reiter M — April 2011
  264. 318JournalLyme borreliosis in dogs and humans in the USALittle SE, Heise SR, Blagburn BL, Callister SM, Mead PS — April 2010
  265. 319JournalLyme borreliosis in dogs and cats: background, diagnosis, treatment and prevention of infections with Borrelia burgdorferi sensu strictoKrupka I, Straubinger RK — November 2010
  266. 320JournalLyme arthritis: an epidemic of oligoarticular arthritis in children and adults in three Connecticut communitiesSteere AC, Malawista SE, Snydman DR, Shope RE, Andiman WA, Ross MR, Steele FM — 1977
  267. 321JournalLyme borreliosis in EuropeRizzoli A, Hauffe H, Carpi G, Vourc'h IG, Neteler M, Rosa R — July 2011
  268. 322JournalTreatment of the early manifestations of Lyme diseaseSteere AC, Hutchinson GJ, Rahn DW, Sigal LH, Craft JE, DeSanna ET, Malawista SE — July 1983
  269. 323JournalLyme disease: prevalence and clinical importance of Borrelia burgdorferi specific IgG in forestry workersGuy EC, Bateman DE, Martyn CN, Heckels JE, Lawton NF — March 1989
  270. 324JournalLyme carditis: a United Kingdom perspectiveHaywood GA, O'Connell S, Gray HH — July 1993
  271. 325JournalWilly Burgdorfer: Lyme diseaseSternbach G, Dibble CL — 1996
  272. 326JournalAbundance of Ixodes scapularis (Acari: Ixodidae) after the complete removal of deer from an isolated offshore island, endemic for Lyme DiseaseRand PW, Lubelczyk C, Holman MS, Lacombe EH, Smith RP — July 2004
  273. 327JournalLyme disease in the eighteenth centurySummerton N — 1995
  274. 328JournalThe prevention of Lyme disease with vaccinePoland GA, Jacobson RM — March 2001
  275. 329JournalAbility of Ixodes persulcatus, Haemaphysalis concinna and Dermacentor silvarum ticks to acquire and transstadially transmit Borrelia gariniiSun Y, Xu R — 2003
  276. 330NewsLukewarm Response To New Lyme VaccineRowe C — 13 June 1999
  277. 331JournalLyme borreliosis: from infection to autoimmunitySingh SK, Girschick HJ — July 2004
  278. 332JournalWhen a vaccine is safeFebruary 2006
  279. 334JournalLyme arthritis and post-Lyme disease syndromeWeinstein A, Britchkov M — July 2002
  280. 335JournalProspective clinical evaluation of patients from Missouri and New York with erythema migrans-like skin lesionsWormser GP, Masters E, Nowakowski J, McKenna D, Holmgren D, Ma K, Ihde L, Cavaliere LF, Nadelman RB — October 2005
  281. 336JournalEpidemiology and diagnosis of Lyme borreliosisWilske B — 2005
  282. 337JournalEstimating Lyme disease risk using pet dogs as sentinelsSmith FD, Ballantyne R, Morgan ER, Wall R — March 2012
  283. 338Lyme DiseaseStaubinger R — Sirius Dog. — 31 May 2000
  284. 339JournalLyme disease: uphill struggleAbbott A — February 2006
  285. 341JournalDiagnosis and management of Lyme diseaseWright WF, Riedel DJ, Talwani R, Gilliam BL — June 2012
  286. 342JournalSerological evidence for tick-borne encephalitis, borreliosis, and human granulocytic anaplasmosis in MongoliaWalder G, Lkhamsuren E, Shagdar A, Bataa J, Batmunkh T, Orth D, Heinz FX, Danichova GA, Khasnatinov MA, Würzner R, Dierich MP — May 2006
  287. 344JournalBorrelia burgdorferi infection and cutaneous Lyme disease, MexicoGordillo-Pérez G, Torres J, Solórzano-Santos F, de Martino S, Lipsker D, Velázquez E, Ramon G, Onofre M, Jaulhac B — October 2007
  288. 345JournalLyme disease. Report of a case observed in BrazilYoshinari NH, Oyafuso LK, Monteiro FG, de Barros PJ, da Cruz FC, Ferreira LG, Bonasser F, Baggio D, Cossermelli W — 1993
  289. 346BookLyme disease: why it's spreading, how it makes you sick, and what to do about itBarbour AG — Johns Hopkins University Press — 2015
  290. 347BookLyme disease: an evidence-based approachCABI — 2025
  291. 349BookLyme Disease: The Ecology of a Complex SystemOstfeld R — Oxford University Press — 2012

Queue